Fortis Healthcare group
Fortis Healthcare and SRL-Ranbaxy are healthcare companies, established by the promoters of Ranbaxy Laboratories, the largest Indian pharmaceutical company with over $1.2 billion in revenues and a product line in over a 100 countries with a ground presence in 44.
Fortis Healthcare Ltd.
Fortis Healthcare has a vision to set up a network of world - class super speciality hospitals linked with a larger network of multi-speciality hospitals to provide high quality healthcare to the people of India, through a hub and spoke model.
In line with its growth strategy and with the recent acquisition of the Escorts Healthcare System, Fortis Healthcare has brought within its fold an additional set of 4 hospitals in the North of India (Escorts Hospital-Amritsar, New Delhi, Faridabad and Raipur) taking its total operational hospital strength to 13 hospitals. The Fortis Healthcare group has progressive plans to change the healthcare delivery landscape in India by being the premier healthcare provider in the region driven by quality and most importantly "patient-centricity".
SRL-Ranbaxy Limited (SRL) was set up in 1997 and established India's First Central Clinical Reference Lab in Mumbai. It was established with the objective of providing cost effective, diagnostically incisive, world-class medical laboratory services in India.
Today, SRL-Ranbaxy is South East Asia's largest Clinical Reference Laboratory, and has successfully conducted over 25 million tests for patients in India, South Asia and the UAE. It has recently commenced servicing a large private hospital group in the UK through outsourced pathology services. Samples are flown out from the UK and post testing in India, the results are electronically communicated over a USFDA compliant IT network.
In India, SRL-Ranbaxy has established a network comprising of one central clinical reference laboratory, 18 satellite laboratories and 550 collection centres. Through this network, it supports over 25,000 doctors, 650 hospitals and close to 1,000 smaller Pathology Labs in 350 towns, across the country.
With the use of over 95 technologies, including the latest cutting-edge inventions and processes, SRL-Ranbaxy offers complete range of over 3,000 clinical laboratory tests for the screening, diagnosis and monitoring of every conceivable disease or metabolic disorder.
Having successfully rendered services for Phase II and III Clinical Trials, there has been a constant demand for SRL to cover other components of the Drug Development process, primarily Phase I studies and Bioequivalence work, including Bioanalysis and Pharmacokinetic samples.
SRL Ranbaxy's commitment to quality assurance is endorsed by the fact that it is India's first CAP (College of American Pathologists) and NABL (National Accreditation Board for Testing and Calibration Laboratories) accredited laboratory and also follows ISO/IEC 17025 standards. The QA/QC and technical standard operating procedures and guidelines meet the benchmarks set by:
- NCCLS (National Committee for Clinical Laboratory Standards, USA)
- CLIA
- GCP and GLP
- WHO and CDC
SRL-Ranbaxy seeks to, not only, retain its dominant position in India but also to substantially expand its overseas operations.
Religare
Religare is driven by ethical and dynamic process for wealth creation. Based on this, the company started its endeavor in the financial market.
Religare Enterprises Limited (A Ranbaxy Promoter Group Company) through Religare Securities Limited, Religare Finvest Limited, Religare Commodities Limited and Religare Insurance Advisory Services Limited provides integrated financial solutions to its corporate, retail and wealth management clients. Today, Religare provides various financial services which include Investment Banking, Corporate Finance, Portfolio Management Services, Equity & Commodity Broking, Insurance and Mutual Funds. Plus, there's a lot more to come your way.
Religare is proud of being a truly professional financial service provider managed by a highly skilled team, who have proven track record in their respective domains. Religare operations are managed by more than 2000 highly skilled professionals who subscribe to Religare philosophy and are spread across its country wide branches.
Religare has a growing network of more than150 branches and more than 300 business partners spread across more than180 cities in India and a fully operational international office at London. However, the target is to have 350 branches and 1000 business partners in 300 cities of India and more than 7 International offices by the end of 2006.
Unlike a traditional broking firm, Religare group works on the philosophy of partnering for wealth creation. Not only trades are executed for its clients but also they are provided with critical and timely investment advice. The growing list of financial institutions with which Religare is empanelled as an approved broker is a reflection of the high level service standard maintained by the company.
|
